The narrative review on the association between smoking and schizophrenia symptoms offers a useful synthesis of a persistently puzzling relationship. Smoking is far more prevalent in people with schizophrenia than in the general population, and it has been linked to symptom severity, cognition, medication effects, and psychosocial outcome. Yet the review, like much of the literature it summarizes, should be read as hypothesis-generating rather than causal. The association is almost certainly bidirectional and heavily confounded: illness severity, negative symptoms, cognitive impairment, antipsychotic treatment, socioeconomic disadvantage, institutionalization, co-occurring substance use, and genetic pleiotropy can all shape both smoking behavior and symptom presentation. Narrative reviews are valuable for mapping this complexity, but they are vulnerable to selection bias and cannot substitute for systematic synthesis, longitudinal designs, Mendelian randomization, and intervention trials.<\/p>\n\n\n\n
A central interpretive problem is that \u201csmoking\u201d is often treated as a unitary exposure. Cigarette smoking, nicotine dependence, heavy smoking, menthol preference, and co-use of cannabis are not interchangeable. Nor are schizophrenia symptoms: positive, negative, cognitive, depressive, and disorganized domains may relate differently to smoking, and subtype differences\u2014such as paranoid versus non-paranoid presentations\u2014may further modify the picture. The self-medication hypothesis remains plausible, especially for negative symptoms and cognitive deficits, but it is insufficient. Nicotine may produce short-term attentional or affective effects that reinforce smoking without improving long-term outcome, while smoking also carries substantial cardiometabolic and mortality risks. The key question is therefore not simply whether smoking is associated with symptoms, but which symptom dimensions, in which patients, through which mechanisms, and with what clinical consequences.<\/p>\n\n\n\n
That question becomes more urgent in the age of artificial intelligence. Problematic internet use\u2014compulsive, uncontrolled, and functionally impairing online engagement\u2014shares several candidate mechanisms with nicotine dependence: reward dysregulation, impulsivity, negative affect regulation, social isolation, and difficulty disengaging from immediately reinforcing stimuli. In people with schizophrenia, negative symptoms, social anxiety, cognitive impairment, and reduced real-world engagement may increase vulnerability to problematic internet use, just as they may increase vulnerability to smoking. AI-mediated environments add new layers: algorithmic feeds, generative chatbots, virtual companions, and personalized content can intensify engagement, blur boundaries between use and dependence, and expose vulnerable users to misinformation, targeted marketing, and emotional over-reliance. These same technologies could also deliver scalable smoking-cessation support, ecological momentary assessment, and digital phenotyping\u2014but only if privacy, equity, and clinical governance are taken seriously.<\/p>\n\n\n\n
The previous review therefore points toward a broader agenda. Smoking and problematic internet use should not be studied as isolated behaviors in schizophrenia but as potentially co-occurring, functionally motivated patterns of affect regulation and reward seeking. Research should examine their shared and distinct correlates across symptom domains, test longitudinal and causal models, and evaluate integrated interventions that address nicotine dependence, digital overuse, negative symptoms, and social functioning together. In the AI era, the commentary is not that smoking research is obsolete, but that the same mechanistic questions\u2014compulsion, self-medication, reward, isolation, and vulnerability\u2014are being replayed in digital environments. A narrative review can open that conversation; the field now needs designs rigorous enough to answer it.<\/p>\n\n\n\n
<\/p>\n\n\n\n
References:<\/p>\n\n\n\n
https:\/\/accscience.com\/journal\/JCBP\/1\/1\/10.36922\/jcbp.1014<\/a><\/p>\n\n\n\n Uludag, K., & Zhao, M. (2023). A narrative review on the association between smoking and schizophrenia symptoms. J Clin Basic Psychosom<\/em>, 1<\/em>(1), 1014.<\/p>\n","protected":false},"excerpt":{"rendered":" The narrative review on the association between smoking and schizophrenia symptoms offers a useful synthesis of a persistently puzzling relationship. Smoking is far more prevalent in people with schizophrenia than in the general population, and it has been linked to Read More …<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4681","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/posts\/4681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/comments?post=4681"}],"version-history":[{"count":1,"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/posts\/4681\/revisions"}],"predecessor-version":[{"id":4682,"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/posts\/4681\/revisions\/4682"}],"wp:attachment":[{"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/media?parent=4681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/categories?post=4681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifx0.com\/index.php\/wp-json\/wp\/v2\/tags?post=4681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}